tiprankstipranks
Trending News
More News >
Barinthus Biotherapeutics Plc (BRNS)
:BRNS
US Market
Advertisement

Barinthus Biotherapeutics (BRNS) Technical Analysis

Compare
101 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Barinthus Biotherapeutics Plc’s (BRNS) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting Barinthus Biotherapeutics Plc is a Sell.
Barinthus Biotherapeutics Plc’s (BRNS) 20-Day exponential moving average is 1.26, while Barinthus Biotherapeutics Plc’s (BRNS) share price is $1.44, making it a Buy.
Barinthus Biotherapeutics Plc’s (BRNS) 50-Day exponential moving average is 1.22, while Barinthus Biotherapeutics Plc’s (BRNS) share price is $1.44, making it a Buy.

Barinthus Biotherapeutics (BRNS) Pivot Points

Oct 05, 2025, 03:32 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.20
1.29
1.36
1.45
1.52
1.61
1.68
Fibonacci
1.29
1.35
1.39
1.45
1.51
1.55
1.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Barinthus Biotherapeutics (BRNS) Moving Averages

Oct 05, 2025, 03:32 PM
Period
Simple
Exponential
MA5
1.42Buy
1.39Buy
MA10
1.29Buy
1.32Buy
MA20
1.19Buy
1.26Buy
MA50
1.25Buy
1.22Buy
MA100
1.15Buy
1.17Buy
MA200
1.06Buy
1.12Buy
Barinthus Biotherapeutics Plc’s (BRNS) 10-Day exponential moving average is 1.32, while Barinthus Biotherapeutics Plc’s (BRNS) share price is $1.44, making it a Buy.
Barinthus Biotherapeutics Plc’s (BRNS) 100-Day exponential moving average is 1.17, while Barinthus Biotherapeutics Plc’s (BRNS) share price is $1.44, making it a Buy.
Barinthus Biotherapeutics Plc’s (BRNS) stock price is $1.44 and Barinthus Biotherapeutics Plc’s (BRNS) 50-day simple moving average is 1.25, creating a Buy signal.
Barinthus Biotherapeutics Plc’s (BRNS) stock price is $1.44 and Barinthus Biotherapeutics Plc’s (BRNS) 100-day simple moving average is 1.15, creating a Buy signal.
Barinthus Biotherapeutics Plc’s (BRNS) stock price is $1.44 and Barinthus Biotherapeutics Plc’s (BRNS) 200-day simple moving average is 1.06, creating a Buy signal.

Barinthus Biotherapeutics (BRNS) Technical Indicators

Oct 05, 2025, 03:32 PM
Name
Value
Implied Action
RSI (14)
59.28
Neutral
STOCH (9,6)
65.61
Neutral
STOCHRSI (14)
68.14
Neutral
MACD (12,26)
0.06
Sell
ADX (14)
25.54
Neutral
Williams %R
-33.82
Buy
CCI (14)
147.11
Sell
ATR (14)
0.16
-
Ultimate Oscillator
59.61
Neutral
ROC
37.14
Buy
Barinthus Biotherapeutics Plc’s (BRNS) Relative Strength Index (RSI) is 59.28, creating a Neutral signal.
Barinthus Biotherapeutics Plc’s (BRNS) Trend Strength Indicator (ADX) is 25.54, creating a Neutral signal.
Barinthus Biotherapeutics Plc’s (BRNS) Commodity Channel Index (CCI) is 147.11, creating a Sell signal.
Barinthus Biotherapeutics Plc’s (BRNS) Price Rate of Change (ROC) is 37.14, creating a Buy signal.

FAQ

Is BRNS a Buy, Hold, or Sell?
Based on BRNS’s technical indicators, BRNS is a Strong Buy.
    What is BRNS’s RSI (14)?
    BRNS’s RSI (14) is 59.28, which suggests BRNS is a Neutral.
      What is BRNS’s MACD?
      BRNS’s MACD is 0.06, which suggests BRNS is a Sell.
        What is BRNS’s 5-day moving average?
        BRNS’s 5-day moving average is 1.42, which suggests BRNS is a Buy.
          What is BRNS’s 20-day moving average?
          BRNS 20-day moving average is 1.19, which suggests BRNS is a Buy.
            What is BRNS’s 50-day moving average?
            BRNS’s 50-day moving average is 1.25, which suggests BRNS is a Buy.
              What is BRNS’s 200-day moving average?
              BRNS’s 200-day moving average is 1.06, which suggests BRNS is a Buy.
                What is BRNS’s Williams % R (14)?
                BRNS’s Williams % R (14) is -33.82, which suggests BRNS is a Buy.
                  What is BRNS’s CCI (14)?
                  BRNS’s CCI (14) is 147.11, which suggests BRNS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis